Main > RARE DISEASES (**) > Multicentric Castleman Disease. > TREAT. > Co: UK. E. SiltuxiMAb Infusion

---

Co: UK. E. SiltuxiMAb Infusion's subsections
(*) CA Approval Date: ?
(*) EU Approval Date: 2014. 06.04.
(*) KR Approval Date: ?
(*) USA Approval Date: 2014. 04.23.
Company
Company Discovery & Dev.
Global Rights ACQ. PR Web-Site
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 3
Patent>UpDate: 2018. 08.14
TradeMark
TradeMark Web-Site

Co: UK. E. SiltuxiMAb Infusion's products
This section has no products